Table 4.

Multivariate models of prognostic factors for PFS and OS, for all patients, and for those who received modern therapy (rituximab and anthracycline).

	PFS			OS
Variable	HR	95% CI	p Value	HR	95% CI	p Value
All patients (n = 120)
Age (continuous)	1.03	1.01–1.05	.013	1.06	1.03–1.08	<.001
Stage (advanced vs. early)	1.93	1.12–3.34	.018	2.45	1.33–4.49	.004
Anthracycline	0.39	0.20–0.76	.006	0.23	0.12–0.46	<.001
Testicular radiation	0.39	0.24–0.64	<.001	0.47	0.27–0.83	.009
Modern therapy patients (n = 64)
Age (continuous)	-	-	-	1.05	1.02–1.09	.004
CNS Prophylaxis	0.28	0.12–0.69	.005	-	-	-
Testicular radiation	0.29	0.13–0.64	.002	0.50	0.21–1.18	.114